Chair(s): Silke Van Koningsbruggen-Rietschel, Nicholas Simmonds

Session type: Pro and con debate

Scott Bell, Carlo Castellani

Session content

To understand the changing landscape with CFTR modulators; to gain knowledge about the PROs and CONs for stopping symptomatic pulmonary therapies; to become familiar with potential future models of CF care.